scholarly journals Peritoneal infections in patients on long-term peritoneal dialysis before and after human cadaveric renal transplantation

1969 ◽  
Vol 22 (5) ◽  
pp. 539-544 ◽  
Author(s):  
D. A. Leigh
1989 ◽  
Vol 9 (1) ◽  
pp. 75-78 ◽  
Author(s):  
Min Sun Park ◽  
Jean Lee ◽  
Moon Sung Lee ◽  
Seung Ho Baick ◽  
Seung Duk Hwang ◽  
...  

In order to evaluate peritoneal membrane function and responsiveness of peritoneal microcirculation to vasoactive agents in long-term continuous ambulatory peritoneal dialysis (CAPD) patients, we studied peritoneal clearances of urea (Curea) and creatinine (Ccr), protein concentrations in drained dialysate (D PC), peritoneal glucose absorption (% GA), and drained dialysate volume ( VD) before and after nitroprusside (NP) addition to dialysis solution in 17 long-term CAPD patients (mean duration of CAPD: 52 months) and the results were compared to those of 18 patients who were just trained for CAPD (mean duration: 0.6 month). There were no differences in the control (without NP) Curea, Ccr, D PC, %GA, and VD between the new and long-term CAPD patients. Curea, Ccr, and D PC increased significantly with NP in both new and long-term patients. Curea and Ccr with NP were not different between the new and long-term patients but D PC with NP was significantly lower in the long-term CAPD patients. The results of this study suggest that peritoneal solute clearances and the responsiveness of peritoneal microcirculation to NP remain unchanged after four years of CAPD, despite recurrent episodes of peritonitis.


1999 ◽  
Vol 19 (6) ◽  
pp. 634-640 ◽  
Author(s):  
Lionel Rostaing ◽  
Marie-Hélène Chabannier ◽  
Anne Modesto ◽  
Anne Rouzaud ◽  
Jean-Marc Cisterne ◽  
...  

1998 ◽  
Vol 65 (Supplement) ◽  
pp. 220
Author(s):  
Z Bahadurali ◽  
A M D'Alessandro ◽  
S J Knechtle ◽  
J S Odorico ◽  
B N Becker ◽  
...  

2016 ◽  
Vol 29 (9) ◽  
pp. 525
Author(s):  
Sofia Deuchande ◽  
Tânia Mano ◽  
Cristina Novais ◽  
Rute Machado ◽  
Rosário Stone ◽  
...  

Introduction: Peritoneal dialysis is the dialytic method of choice in chronic end-stage renal disease in children. This study main purposewas to characterize the long-term survival of a pediatric population who began peritoneal dialysis within the first two years of life.Material and Methods: A descriptive and retrospective study was performed in a portuguese nephrology and renal transplantation pediatric unit, between January 1991 and August 2014. End-stage renal disease etiology, mortality, comorbidities and complications of peritoneal dialysis and end-stage renal disease, growth and psychomotor development were evaluated.Results: Twenty children started peritoneal dialysis within the first two years of life. There were six deaths, but no deaths of children with primary chronic kidney disease were registered over the past decade. The 14 living children were characterized; 13 were males. Congenital abnormalities of the kidney and urinary tract were the leading etiology of chronic kidney disease (45%). The average age start of peritoneal dialysis was 6.1 months; six children started before 30 days of life. Peritonitis was the most frequent cause of hospitalization. Ten children were transplanted at an average age of 5.3 years. All of the children who are still in peritoneal dialysis have short stature, but nine of the transplanted have final height within the expected for their mid-parental height target range. Nine (64%)had some type of neurodevelopmental delay.Discussion: Peritoneal dialysis is a technique possible and feasible since birth, as evidenced in the study, as more than half of children successfully started it before 6 months of life. It allows long-term survival until the possibility of renal transplantation despite the associated morbidity, including peritonitis and complications of chronic renal disease. The ten transplanted children improved their growth, recovered from chronic anemia and improved dyslipidemia, compared with the period of dialysis. However, the average waiting time until the renal transplant was 5.3 years higher than other international centers.Conclusion: These data support the use of peritoneal dialysis from birth, but complications and the worst growth reflect the need to develop strategies to optimize care relating to nutrition, growth and development and to reduce pre-transplant time.


BMJ ◽  
1985 ◽  
Vol 291 (6501) ◽  
pp. 1004-1007 ◽  
Author(s):  
J B Evangelista ◽  
D Bennett-Jones ◽  
J S Cameron ◽  
C Ogg ◽  
D G Williams ◽  
...  

2002 ◽  
Vol 167 (2 Part 1) ◽  
pp. 477-479 ◽  
Author(s):  
RICHARD E. POWER ◽  
KIARAN J. O’MALLEY ◽  
DILLY M. LITTLE ◽  
MARY G. DONOVAN ◽  
TOM A. CREAGH ◽  
...  

1983 ◽  
Vol 129 (4) ◽  
pp. 884-884
Author(s):  
E. Savdie ◽  
J.F. Mahony ◽  
R.J. Caterson ◽  
J.H. Stewart ◽  
S. Ethredge ◽  
...  

1996 ◽  
Vol 7 (5) ◽  
pp. 792-797
Author(s):  
C Ponticelli ◽  
G Civati ◽  
A Tarantino ◽  
F Quarto di Palo ◽  
G Corbetta ◽  
...  

This study presents the 10-yr follow-up results of a multicenter controlled trial on 108 recipients of cadaveric renal transplantation, randomized to receive cyclosporine (N = 55) or azathioprine (N = 53), both in combination with steroids. The 10-yr patient survival rate was 89% in the cyclosporine group and 83% in the azathioprine group (P = not significant [NS]); the 10-yr graft survival was 56% and 35%, respectively (log-rank test, P = 0.009). The half-life of grafts functioning after 1 yr was 15.4 +/- 3.9 versus 10.6 +/- 3.6, P = NS). The rate of early rejection in the cyclosporine group was significantly lower than that in the azathioprine group (0.30 versus 1.4, P < 0.01). Although the mean creatinine clearance rate was always higher in the azathioprine group, the decline in graft function from the first to the tenth yr was not significantly different between the two groups (-13.0 +/- 16.4 versus -12.3 +/- 19 mL/min, P = NS). In cadaveric renal transplantation, cyclosporine allows better graft survival than azathioprine, not only in the short term but also in the long term, with similar attrition of graft function for up to 10 yr.


Sign in / Sign up

Export Citation Format

Share Document